WallStreetZenWallStreetZen

NASDAQ: IMRN
Immuron Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their IMRN stock forecasts and price targets.

Forecast return on equity

Is IMRN forecast to generate an efficient return?

Company
-35.06%
Industry
85.14%
Market
61.59%
IMRN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IMRN forecast to generate an efficient return on assets?

Company
-29.79%
Industry
23.59%
IMRN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IMRN revenue forecast

What is IMRN's revenue in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
$3.8M-38.67%
IMRN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IMRN revenue growth forecast

How is IMRN forecast to perform vs Biotechnology companies and vs the US market?

Company
28.48%
Industry
149.96%
Market
10.5%
IMRN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IMRN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IMRN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IMRN$1.87N/AN/A
ERNA$0.21N/AN/A
CAPS$2.00N/AN/A
IBIO$1.05$6.00+471.43%Strong Buy
BTAI$1.99$49.25+2,374.87%Buy
View Top Biotech Stocks

Immuron Stock Forecast FAQ

What is IMRN's revenue growth forecast for 2025-2025?

(NASDAQ: IMRN) Immuron's forecast annual revenue growth rate of 28.48% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 149.96%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.5%.

Immuron's revenue in 2025 is $6,257,751.

In 2025, IMRN is forecast to generate $864,113,731 in revenue, with the lowest revenue forecast at $864,113,731 and the highest revenue forecast at $864,113,731.

If you're new to stock investing, here's how to buy Immuron stock.

What is IMRN's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: IMRN) forecast ROA is -29.79%, which is lower than the forecast US Biotechnology industry average of 23.59%.

What is IMRN's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: IMRN) forecast ROE is -35.06%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.